Details for New Drug Application (NDA): 011073
✉ Email this page to a colleague
NDA 011073 describes WAMPOCAP, which is a drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional details are available on the WAMPOCAP profile page.
The generic ingredient in WAMPOCAP is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
The generic ingredient in WAMPOCAP is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
Summary for 011073
| Tradename: | WAMPOCAP |
| Applicant: | Medpointe Pharm Hlc |
| Ingredient: | niacin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011073
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
